Skip to main content
. 2022 Mar 1;11(3):e34688. doi: 10.2196/34688

Table 1.

Measurement instruments.

Instrument or assessment Outcome
Background and Health Survey Detailed demographic, health, and lifestyle characteristics
Intervention engagement System reports of course enrolment and progression and newsletter engagement; self-report intervention and community activity engagement data
Knowledge of Dementia Risk Reduction Survey Knowledge of dementia risk; recall and recognition of modifiable and nonmodifiable dementia risk factors
Motivation to Change Lifestyle and Health Behaviours for Dementia Risk Reduction Scale [40] Beliefs and attitudes toward lifestyle and behavioral changes for dementia risk reduction
All Aspects of Health Literacy Scalea [43] Functional, communicative, and critical health literacy
New General Self-Efficacy Scalea [42] Perceived ability to achieve a range of different types of task.
Dementia Risk Profile Behaviors affecting dementia risk factors: diagnosis, regular checks and management of cardiometabolic health; BMI; physical and cognitive activity; diet, alcohol consumption, and smoking
Hospital Anxiety and Depression Scale [48] Symptom severity for 2 dimensions (anxiety and depression); pooled score indicates psychological distress
Perceived Stress Scalea [44] Extent to which daily life is perceived as stressful
Lubben Social Network Scale [49] Extent of social networks; 3 dimensions (family, neighbors and friends)
Assessment of Quality of Life [50] Multiattribute utility instrument that generates psychometric and Quality of Life Years scores based on 8 dimensions of health-related quality of life: physical health (independent living, pain, and senses) and psychosocial health (mental health, happiness, coping, relationships, and self-worth)
Written reflection task [51] Cognitive performance: idea density, grammar, and sentence construction
Talk2Me Online [23] Cognitive performance: image naming, picture description, and audio files providing approximately 2000 lexicosyntactic, acoustic, and semantic features for analysis
Cambridge Neuropsychological Test Automated Battery Online [45] Cognitive performance: Paired Associates Learning captures learning and recall of visual information over successive trials and is sensitive to cognitive decline in early Alzheimer disease and mild cognitive impairment [52] Spatial Working Memory assesses executive function, retention, and manipulation of visuospatial information
TAS Test [47] Motor and cognitive performance using keyboard tapping, visuomotor reaction tests, and visuospatial working memory tests providing approximately 1000 motor-cognitive features for analysis
Blood samples Biomarker levels indicative of dementia pathology (eg, beta-amyloid, phosphorylated tau, and neurofilament light) measured in plasma or serum using enzyme-linked immunoassay, SIMOA,b and mass spectrometry
Genetics Candidate gene markers related to Alzheimer disease such as apolipoprotein epsilon-E and the brain-derived neurotrophic factor polymorphism measured via blood samples

aInstruments only administered to some participants.

bSIMOA: Single Molecule Array.